# Cboe Global Markets, Inc.: financial statements, quarterly

CBOE · CBOE · CIK 1374310 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cboe.md) · [Financials](/companies/cboe/financials.md) · [Filings](/companies/cboe/filings.md) · [Insiders](/companies/cboe/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cboe/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [909](/filings/0001628280-24-044657.md) | [969 d](/filings/0001628280-26-010013.md) | [957](/filings/0001628280-25-021680.md) | [974](/filings/0001628280-25-037149.md) | [1,056](/filings/0001628280-25-047680.md) | [1,108 d](/filings/0001628280-26-010013.md) | [1,195](/filings/0001628280-26-029112.md) | [1,174](/filings/0001628280-26-051239.md) | [1,142](/filings/0001628280-25-047680.md) | [1,204 d](/filings/0001628280-26-010013.md) | [1,273](/filings/0001628280-26-029112.md) | [1,443](/filings/0001628280-26-051239.md) |
| Cost of revenue | $m | [428](/filings/0001628280-24-044657.md) | [470 d](/filings/0001628280-26-010013.md) | [455](/filings/0001628280-25-021680.md) | [460](/filings/0001628280-25-037149.md) | [524](/filings/0001628280-25-047680.md) | [583 d](/filings/0001628280-26-010013.md) | [630](/filings/0001628280-26-029112.md) | [586](/filings/0001628280-26-051239.md) | [536](/filings/0001628280-25-047680.md) | [533 d](/filings/0001628280-26-010013.md) | [544](/filings/0001628280-26-029112.md) | [711](/filings/0001628280-26-051239.md) |
| Gross profit | $m | [481](/filings/0001628280-24-044657.md) | [499 d](/filings/0001628280-26-010013.md) | [502](/filings/0001628280-25-021680.md) | [514](/filings/0001628280-25-037149.md) | [532](/filings/0001628280-25-047680.md) | [525 d](/filings/0001628280-26-010013.md) | [565](/filings/0001628280-26-029112.md) | [587](/filings/0001628280-26-051239.md) | [606](/filings/0001628280-25-047680.md) | [671 d](/filings/0001628280-26-010013.md) | [729](/filings/0001628280-26-029112.md) | [732](/filings/0001628280-26-051239.md) |
| Operating income | $m | [271](/filings/0001628280-24-044657.md) | [294 d](/filings/0001628280-26-010013.md) | [282](/filings/0001628280-25-021680.md) | [210](/filings/0001628280-25-037149.md) | [307](/filings/0001628280-25-047680.md) | [299 d](/filings/0001628280-26-010013.md) | [354](/filings/0001628280-26-029112.md) | [339](/filings/0001628280-26-051239.md) | [370](/filings/0001628280-25-047680.md) | [404 d](/filings/0001628280-26-010013.md) | [506](/filings/0001628280-26-029112.md) | [476](/filings/0001628280-26-051239.md) |
| Interest expense | $m | [15.4](/filings/0001628280-24-044657.md) | [13.2 d](/filings/0001628280-26-010013.md) | [13.0](/filings/0001628280-25-021680.md) | [12.8](/filings/0001628280-25-037149.md) | [12.8](/filings/0001628280-25-047680.md) | [12.9 d](/filings/0001628280-26-010013.md) | [12.8](/filings/0001628280-26-029112.md) | [12.9](/filings/0001628280-26-051239.md) | [13.3](/filings/0001628280-25-047680.md) | [13.3 d](/filings/0001628280-26-010013.md) | [13.3](/filings/0001628280-26-029112.md) | [13.2](/filings/0001628280-26-051239.md) |
| Income tax | $m | [61.9](/filings/0001628280-24-044657.md) | [75.5 d](/filings/0001628280-26-010013.md) | [82.6](/filings/0001628280-25-021680.md) | [62.6](/filings/0001628280-25-037149.md) | [90.5](/filings/0001628280-25-047680.md) | [83.2 d](/filings/0001628280-26-010013.md) | [99.6](/filings/0001628280-26-029112.md) | [99.5](/filings/0001628280-26-051239.md) | [129](/filings/0001628280-25-047680.md) | [138 d](/filings/0001628280-26-010013.md) | [130](/filings/0001628280-26-029112.md) | [142](/filings/0001628280-26-051239.md) |
| Net income | $m | [208](/filings/0001628280-24-044657.md) | [212 d](/filings/0001628280-26-010013.md) | [210](/filings/0001628280-25-021680.md) | [140](/filings/0001628280-25-037149.md) | [219](/filings/0001628280-25-047680.md) | [197 d](/filings/0001628280-26-010013.md) | [251](/filings/0001628280-26-029112.md) | [235](/filings/0001628280-26-051239.md) | [301](/filings/0001628280-25-047680.md) | [314 d](/filings/0001628280-26-010013.md) | [386](/filings/0001628280-26-029112.md) | [353](/filings/0001628280-26-051239.md) |
| Diluted EPS | $ per share | [1.95](/filings/0001628280-24-044657.md) | not reported | [1.96](/filings/0001628280-25-021680.md) | [1.33](/filings/0001628280-25-037149.md) | [2.07](/filings/0001628280-25-047680.md) | not reported | [2.37](/filings/0001628280-26-029112.md) | [2.23](/filings/0001628280-26-051239.md) | [2.85](/filings/0001628280-25-047680.md) | not reported | [3.66](/filings/0001628280-26-029112.md) | [3.35](/filings/0001628280-26-051239.md) |
| Basic EPS | $ per share | [1.96](/filings/0001628280-24-044657.md) | not reported | [1.97](/filings/0001628280-25-021680.md) | [1.33](/filings/0001628280-25-037149.md) | [2.08](/filings/0001628280-25-047680.md) | not reported | [2.38](/filings/0001628280-26-029112.md) | [2.23](/filings/0001628280-26-051239.md) | [2.86](/filings/0001628280-25-047680.md) | not reported | [3.67](/filings/0001628280-26-029112.md) | [3.36](/filings/0001628280-26-051239.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.4](/filings/0001558370-23-017503.md) | [0.5](/filings/0001628280-25-006984.md) | [0.5](/filings/0001558370-24-006597.md) | [0.6](/filings/0001558370-24-010654.md) | [0.8](/filings/0001628280-24-044657.md) | [0.9](/filings/0001628280-26-010013.md) | [1.0](/filings/0001628280-25-021680.md) | [1.3](/filings/0001628280-25-037149.md) | [1.5](/filings/0001628280-25-047680.md) | [2.2](/filings/0001628280-26-051239.md) | [2.1](/filings/0001628280-26-029112.md) | [2.3](/filings/0001628280-26-051239.md) |
| Current assets | $bn | [2.3](/filings/0001558370-23-017503.md) | [2.0](/filings/0001628280-25-006984.md) | [2.7](/filings/0001558370-24-006597.md) | [3.9](/filings/0001558370-24-010654.md) | [3.3](/filings/0001628280-24-044657.md) | [2.5](/filings/0001628280-26-010013.md) | [3.4](/filings/0001628280-25-021680.md) | [3.7](/filings/0001628280-25-037149.md) | [3.7](/filings/0001628280-25-047680.md) | [4.4](/filings/0001628280-26-051239.md) | [6.2](/filings/0001628280-26-029112.md) | [5.9](/filings/0001628280-26-051239.md) |
| Total assets | $bn | [7.7](/filings/0001558370-23-017503.md) | [7.5](/filings/0001628280-25-006984.md) | [8.2](/filings/0001558370-24-006597.md) | [9.3](/filings/0001558370-24-010654.md) | [8.7](/filings/0001628280-24-044657.md) | [7.8](/filings/0001628280-26-010013.md) | [8.7](/filings/0001628280-25-021680.md) | [9.0](/filings/0001628280-25-037149.md) | [9.1](/filings/0001628280-25-047680.md) | [9.3](/filings/0001628280-26-051239.md) | [11.1](/filings/0001628280-26-029112.md) | [10.6](/filings/0001628280-26-051239.md) |
| Current liabilities | $bn | [1.8](/filings/0001558370-23-017503.md) | [1.4](/filings/0001628280-25-006984.md) | [2.0](/filings/0001558370-24-006597.md) | [3.2](/filings/0001558370-24-010654.md) | [2.4](/filings/0001628280-24-044657.md) | [1.4](/filings/0001628280-26-010013.md) | [2.1](/filings/0001628280-25-021680.md) | [2.4](/filings/0001628280-25-037149.md) | [2.2](/filings/0001628280-25-047680.md) | [2.4](/filings/0001628280-26-051239.md) | [4.5](/filings/0001628280-26-029112.md) | [3.8](/filings/0001628280-26-051239.md) |
| Total liabilities | $bn | [3.9](/filings/0001558370-23-017503.md) | [3.5](/filings/0001628280-25-006984.md) | [4.1](/filings/0001558370-24-006597.md) | [5.2](/filings/0001558370-24-010654.md) | [4.5](/filings/0001628280-24-044657.md) | [3.5](/filings/0001628280-26-010013.md) | [4.2](/filings/0001628280-25-021680.md) | [4.4](/filings/0001628280-25-037149.md) | [4.2](/filings/0001628280-25-047680.md) | [4.2](/filings/0001628280-26-051239.md) | [5.7](/filings/0001628280-26-029112.md) | [5.0](/filings/0001628280-26-051239.md) |
| Long-term debt | $bn | [1.4](/filings/0001558370-23-017503.md) | [1.4](/filings/0001628280-25-006984.md) | [1.4](/filings/0001558370-24-006597.md) | [1.4](/filings/0001558370-24-010654.md) | [1.4](/filings/0001628280-24-044657.md) | [1.4](/filings/0001628280-26-010013.md) | [1.4](/filings/0001628280-25-021680.md) | [1.4](/filings/0001628280-25-037149.md) | [1.4](/filings/0001628280-25-047680.md) | [1.4](/filings/0001628280-26-051239.md) | [0.8](/filings/0001628280-26-029112.md) | [0.8](/filings/0001628280-26-051239.md) |
| Current portion of debt | $bn | [0.1](/filings/0001558370-23-017503.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-26-051239.md) | [0.6](/filings/0001628280-26-029112.md) | [0.6](/filings/0001628280-26-051239.md) |
| Shareholders' equity | $bn | [3.8](/filings/0001628280-24-044657.md) | [4.0](/filings/0001628280-26-010013.md) | [4.0](/filings/0001628280-25-047680.md) | [4.0](/filings/0001628280-25-047680.md) | [4.2](/filings/0001628280-25-047680.md) | [4.3](/filings/0001628280-26-051239.md) | [4.5](/filings/0001628280-26-051239.md) | [4.7](/filings/0001628280-26-051239.md) | [4.9](/filings/0001628280-25-047680.md) | [5.1](/filings/0001628280-26-051239.md) | [5.4](/filings/0001628280-26-051239.md) | [5.6](/filings/0001628280-26-051239.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [737 d](/filings/0001628280-24-044657.md) | [(189) d](/filings/0001628280-26-010013.md) | [896](/filings/0001628280-25-021680.md) | [1,494 d](/filings/0001628280-25-037149.md) | [(579) d](/filings/0001628280-25-047680.md) | [(710) d](/filings/0001628280-26-010013.md) | [913](/filings/0001628280-26-029112.md) | [334 d](/filings/0001628280-26-051239.md) | [154 d](/filings/0001628280-25-047680.md) | [352 d](/filings/0001628280-26-010013.md) | [1,960](/filings/0001628280-26-029112.md) | [(503) d](/filings/0001628280-26-051239.md) |
| Capital expenditure | $m | [7.7 d](/filings/0001628280-24-044657.md) | [17.1 d](/filings/0001628280-26-010013.md) | [7.3](/filings/0001628280-25-021680.md) | [17.8 d](/filings/0001628280-25-037149.md) | [12.0 d](/filings/0001628280-25-047680.md) | [23.8 d](/filings/0001628280-26-010013.md) | [14.7](/filings/0001628280-26-029112.md) | [20.3 d](/filings/0001628280-25-037149.md) | [16.0 d](/filings/0001628280-25-047680.md) | [20.0 d](/filings/0001628280-26-010013.md) | [19.2](/filings/0001628280-26-029112.md) | [33.1 d](/filings/0001628280-26-051239.md) |
| Dividends paid | $m | [58.5 d](/filings/0001628280-24-044657.md) | [58.5 d](/filings/0001628280-26-010013.md) | [58.5](/filings/0001628280-25-021680.md) | [58.2 d](/filings/0001628280-25-037149.md) | [66.3 d](/filings/0001628280-25-047680.md) | [66.4 d](/filings/0001628280-26-010013.md) | [66.4](/filings/0001628280-26-029112.md) | [66.4 d](/filings/0001628280-26-051239.md) | [75.7 d](/filings/0001628280-25-047680.md) | [75.8 d](/filings/0001628280-26-010013.md) | [75.8](/filings/0001628280-26-029112.md) | [75.7 d](/filings/0001628280-26-051239.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-24-044657.md) | [5.8 d](/filings/0001628280-26-010013.md) | [76.6](/filings/0001628280-25-021680.md) | [101 d](/filings/0001628280-25-037149.md) | [26.4 d](/filings/0001628280-25-047680.md) | [0.5 d](/filings/0001628280-26-010013.md) | [30.0](/filings/0001628280-26-029112.md) | [36.7 d](/filings/0001628280-26-051239.md) | [0.0 d](/filings/0001628280-25-047680.md) | [0.0 d](/filings/0001628280-26-010013.md) | [40.9](/filings/0001628280-26-029112.md) | [34.4 d](/filings/0001628280-26-051239.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [106](/filings/0001558370-23-017503.md) | [106](/filings/0001558370-24-006597.md) | [106](/filings/0001558370-24-010654.md) | [106](/filings/0001628280-24-044657.md) | [106](/filings/0001628280-25-021680.md) | [105](/filings/0001628280-25-037149.md) | [105](/filings/0001628280-25-047680.md) | [105](/filings/0001628280-26-029112.md) | [105](/filings/0001628280-26-051239.md) | [105](/filings/0001628280-25-047680.md) | [105](/filings/0001628280-26-029112.md) | [105](/filings/0001628280-26-051239.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 104,431,019 at 2026-07-24, from the cover of the [10-Q filed 2026-07-31](/filings/0001628280-26-051239.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.